Thomas Quaschning

2.5k total citations · 1 hit paper
54 papers, 2.1k citations indexed

About

Thomas Quaschning is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas Quaschning has authored 54 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas Quaschning's work include Renin-Angiotensin System Studies (15 papers), Nitric Oxide and Endothelin Effects (13 papers) and Hormonal Regulation and Hypertension (11 papers). Thomas Quaschning is often cited by papers focused on Renin-Angiotensin System Studies (15 papers), Nitric Oxide and Endothelin Effects (13 papers) and Hormonal Regulation and Hypertension (11 papers). Thomas Quaschning collaborates with scholars based in Germany, Switzerland and Czechia. Thomas Quaschning's co-authors include Thomas F. Lüscher, Christoph Wanner, Sidney Shaw, Jan Galle, Frank Ruschitzka, Ralf Labugger, Jeremy N. Skepper, Juliane Kilo, Tadeusz Maliñski and Bernd van der Loo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Thomas Quaschning

53 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced Peroxynitrite Formation Is Associated with Vascular Aging

2000 569 citations Thomas Quaschning, Thomas F. Lüscher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Quaschning Germany	23	674	633	431	384	368	54	2.1k
Masao Kakoki United States	31	689 1.0×	709 1.1×	1.1k 2.5×	477 1.2×	358 1.0×	53	3.0k
Tomohiro Osanai Japan	30	562 0.8×	1.2k 1.8×	815 1.9×	296 0.8×	323 0.9×	141	2.7k
Ah Siew Sim Australia	16	715 1.1×	673 1.1×	310 0.7×	276 0.7×	266 0.7×	17	1.7k
Jeremy D. Ollerenshaw United States	14	1.1k 1.7×	1.1k 1.8×	835 1.9×	472 1.2×	414 1.1×	27	3.0k
Hidehiro Matsuoka Japan	23	1.3k 2.0×	1.5k 2.4×	356 0.8×	283 0.7×	639 1.7×	31	3.0k
Eddie L. Greene United States	28	411 0.6×	611 1.0×	1.0k 2.4×	426 1.1×	415 1.1×	63	2.8k
Nobuyuki Ura Japan	27	582 0.9×	1.3k 2.0×	551 1.3×	754 2.0×	329 0.9×	98	3.2k
P J Shultz United States	17	1.1k 1.7×	736 1.2×	615 1.4×	164 0.4×	172 0.5×	20	2.1k
Friedrich Schulze Germany	22	1.2k 1.8×	1.3k 2.0×	324 0.8×	420 1.1×	574 1.6×	39	2.9k
Wing-Sun Chow Hong Kong	19	722 1.1×	762 1.2×	385 0.9×	609 1.6×	316 0.9×	38	2.5k

Countries citing papers authored by Thomas Quaschning

Since Specialization

Citations

This map shows the geographic impact of Thomas Quaschning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Quaschning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Quaschning more than expected).

Fields of papers citing papers by Thomas Quaschning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Quaschning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Quaschning. The network helps show where Thomas Quaschning may publish in the future.

Co-authorship network of co-authors of Thomas Quaschning

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Quaschning. A scholar is included among the top collaborators of Thomas Quaschning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Quaschning. Thomas Quaschning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hocher, Berthold, Philipp Kalk, Michael Godes, et al.. (2008). Gender-Dependent Impact of Risk Factors for Cardiovascular and Non-Cardiovascular Mortality in End-Stage Renal Disease Patients on Haemodialysis. Kidney & Blood Pressure Research. 31(5). 360–366. 7 indexed citations

Bender, Bernhard U., et al.. (2007). A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiency. Clinical Chemistry and Laboratory Medicine (CCLM). 45(4). 483–6. 2 indexed citations

Elverfeldt, Dominik von, Thomas Quaschning, André El Saman, et al.. (2007). Kinetics of PME/Pi in pig kidneys during cold ischemia. NMR in Biomedicine. 20(7). 652–657. 4 indexed citations

Quaschning, Thomas, Florian Voß, Katharina Relle, et al.. (2007). Lack of Endothelial Nitric Oxide Synthase Promotes Endothelin-Induced Hypertension. Journal of the American Society of Nephrology. 18(3). 730–740. 55 indexed citations

Hofmann, Ulrich, Stefan Heuer, J Boehler, et al.. (2007). The proinflammatory cytokines TNF-α and IL-1β impair economy of contraction in human myocardium. Cytokine. 39(3). 157–162. 32 indexed citations

Quaschning, Thomas. (2005). Vasopeptidase Inhibition for Blood Pressure Control: Emerging Experience. Current Pharmaceutical Design. 11(25). 3293–3299. 12 indexed citations

Nahrendorf, Matthias, Matthias Spindler, Kai Hu, et al.. (2004). Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction. Cardiovascular Research. 65(2). 419–427. 51 indexed citations

Quaschning, Thomas. (2003). Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic mice. Nephrology Dialysis Transplantation. 18(3). 479–483. 21 indexed citations

Quaschning, Thomas, Jan Galle, & Christoph Wanner. (2003). Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction. Kidney International. 63(84). S54–S57. 16 indexed citations

10.

Galle, Jan, Steffen‐Sebastian Bolz, Stepan Gambaryan, et al.. (2003). Oxidized LDL and its Compound Lysophosphatidylcholine Potentiate AngII-Induced Vasoconstriction by Stimulation of RhoA. Journal of the American Society of Nephrology. 14(6). 1471–1479. 41 indexed citations

11.

Galle, Jan, Thomas Quaschning, Stefan Seibold, & Christoph Wanner. (2003). Endothelial dysfunction and inflammation: What is the link?. Kidney International. 63(84). S45–S49. 78 indexed citations

12.

Quaschning, Thomas, Livius V. d’Uscio, Sidney Shaw, et al.. (2001). Vasopeptidase Inhibition Restores Renovascular Endothelial Dysfunction in Salt-Induced Hypertension. Journal of the American Society of Nephrology. 12(11). 2280–2287. 33 indexed citations

13.

Galle, Jan & Thomas Quaschning. (2001). Angiotensin II and Atherosclerosis: Relevance for Renal Disease. Contributions to nephrology. 235–249. 4 indexed citations

14.

Quaschning, Thomas, Livius V. d’Uscio, Sidney Shaw, et al.. (2001). Chronic vasopeptidase inhibition restores endothelin‐converting enzyme activity and normalizes endothelin levels in salt‐induced hypertension. Nephrology Dialysis Transplantation. 16(6). 1176–1182. 9 indexed citations

15.

Quaschning, Thomas, et al.. (2000). Aldosterone Receptor Antagonism Normalizes Vascular Function in 11β-Hydroxysteroid Dehydrogenase Deficient Hypertension. Hypertension. 36. 691–691. 1 indexed citations

16.

Quaschning, Thomas, et al.. (1999). Abnormalities in lipoprotein metabolism in hemodialysis patients. Kidney International. 56. S248–S250. 22 indexed citations

17.

Quaschning, Thomas, et al.. (1999). Immunosuppression enhances atherogenicity of lipid profile after transplantation. Kidney International. 56. S235–S237. 53 indexed citations

18.

Quaschning, Thomas, Michael Schömig, Markus A. Keller, et al.. (1999). Non-Insulin-Dependent Diabetes Mellitus and Hypertriglyceridemia Impair Lipoprotein Metabolism in Chronic Hemodialysis Patients. Journal of the American Society of Nephrology. 10(2). 332–341. 21 indexed citations

19.

Quaschning, Thomas. (1998). The patient with asymptomatic acute renal failure - renal biopsy gives the diagnosis. Nephrology Dialysis Transplantation. 13(8). 2147–2148.

20.

Krämer‐Guth, Annette, Hermann Pavenstädt, Thomas Quaschning, et al.. (1996). Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix. Kidney International. 49(5). 1250–1261. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact